Revenue of Hyphens Pharma International Limited FY 2022, by business segment
In financial year 2022, Hyphens Pharma International Limited reported revenue of just 95.7 million Singapore dollars from its specialty pharma principal segment. This segment involves marketing and selling of more than 30 specialty pharmaceutical products in some ASEAN countries. Hyphens Pharma International is a Singapore-based specialty pharmaceutical and consumer healthcare group operating in Southeast Asian countries.